Literature DB >> 24392261

A case of thrombocytopenia associated with valproic Acid treatment.

Chandra S Nerumalla1, Asim A Shah1.   

Abstract

Entities:  

Year:  2013        PMID： 24392261      PMCID： PMC3869613          DOI： 10.4088/PCC.13l01526

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  5 in total

1.  Hematological effects of valproate in psychiatric patients: what are the risk factors?

Authors:  Kamini Vasudev; Patrick Keown; Ian Gibb; Richard Hamish McAllister-Williams
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

2.  Delayed thrombocytopenia after valproic acid overdose.

Authors:  Wei-Chen Lin; Jian-Hsiungo Tsao; Shih-Jen Tsai
Journal:  Gen Hosp Psychiatry       Date:  2008-07-23       Impact factor: 3.238

3.  Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.

Authors:  E L Conley; K C Coley; B G Pollock; S V Dapos; R Maxwell; R A Branch
Journal:  Pharmacotherapy       Date:  2001-11       Impact factor: 4.705

4.  Successful reintroduction of valproic acid after the occurrence of pancytopenia.

Authors:  Jonathan T Stewart
Journal:  Am J Geriatr Pharmacother       Date:  2011-10-02

Review 5.  Hematologic toxicity of sodium valproate.

Authors:  S Acharya; J B Bussel
Journal:  J Pediatr Hematol Oncol       Date:  2000 Jan-Feb       Impact factor: 1.289
  5 in total
  1 in total

Review 1.  Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.

Authors:  Rosanne W Meijboom; Koen P Grootens
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.